|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：I120055 |
| 產(chǎn)品名稱：dBET1 |
| 產(chǎn)品CAS：1799711-21-9 |
| 規(guī)格含量： |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
I120055 |
| 名稱: |
dBET1 |
| 別名: |
(6S)-4-(4-Chlorophenyl)-N-[4-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]butyl]-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide |
| CAS號: |
1799711-21-9 |
| 分子式: |
C??H??ClN?O?S |
| 分子量: |
785.27 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
dBET1 induces highly selective cereblon-dependent BET protein degradation in vitro and in vivo as well as delays leukemia progression in mice. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
